2nd Quarter - Report
LMH STRATEGIC SOLUTIONS for MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA)
Income
$230,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Prescription drug payment reform. Pharmaceutical Supply Chain.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY CHEVALIER EFANTIS | Legislative Director, Rep. Artur Davis; Legislative Assistant, Rep. Tom Barrett |
| ALANNA TEMME | Legislative Director, U.S. Representative Jon Porter |
| MAXIMILIAN WALTER | — |
Medicare/Medicaid MMM
General Medicare and Medicaid Issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY CHEVALIER EFANTIS | — |
| ALANNA TEMME | — |
| MAXIMILIAN WALTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.